Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Vieyra-Garcia, PA; Wei, T; Naym, DG; Fredholm, S; Fink-Puches, R; Cerroni, L; Odum, N; O'Malley, JT; Gniadecki, R; Wolf, P.
STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides.
Clin Cancer Res. 2016; 22(13):3328-3339
Doi: 10.1158/1078-0432.CCR-15-1784
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Vieyra Garcia Pablo Augusto
-
Wolf Peter
- Co-authors Med Uni Graz
-
Cerroni Lorenzo
-
Fink-Puches Regina
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Sustained inflammation is a key feature of mycosis fungoides (MF), the most common form of cutaneous T-cell lymphoma (CTCL). Resident IL9-producing T cells have been found in skin infections and certain inflammatory skin diseases, but their role in MF is currently unknown.
We analyzed lesional skin from patients with MF for the expression of IL9 and its regulators. To determine which cells were producing IL9, high-throughput sequencing was used to identify malignant clones and Vb-specific antibodies were employed to visualize malignant cells in histologic preparations. To explore the mechanism of IL9 secretion, we knocked down STAT3/5 and IRF4 by siRNA transfection in CTCL cell lines receiving psoralen+UVA (PUVA) ± anti-IL9 antibody. To further examine the role of IL9 in tumor development, the EL-4 T-cell lymphoma model was used in C57BL/6 mice.
Malignant and reactive T cells produce IL9 in lesional skin. Expression of the Th9 transcription factor IRF4 in malignant cells was heterogeneous, whereas reactive T cells expressed it uniformly. PUVA or UVB phototherapy diminished the frequencies of IL9- and IL9r-positive cells, as well as STAT3/5a and IRF4 expression in lesional skin. IL9 production was regulated by STAT3/5 and silencing of STAT5 or blockade of IL9 with neutralizing antibodies potentiated cell death after PUVA treatment in vitro IL9-depleted mice exhibited a reduction of tumor growth, higher frequencies of regulatory T cells, and activated CD4 and CD8 T lymphocytes.
Our results suggest that IL9 and its regulators are promising new targets for therapy development in mycosis fungoides. Clin Cancer Res; 22(13); 3328-39. ©2016 AACR.
©2016 American Association for Cancer Research.
- Find related publications in this database (using NLM MeSH Indexing)
-
Aged -
-
Aged, 80 and over -
-
Animals -
-
CD8-Positive T-Lymphocytes - immunology
-
Cell Line, Tumor -
-
Cell Proliferation -
-
Cell Survival -
-
Female -
-
High-Throughput Nucleotide Sequencing -
-
Humans -
-
Interferon Regulatory Factors - genetics
-
Interferon Regulatory Factors - metabolism
-
Interleukin-9 - biosynthesis
-
Lymphocyte Activation - immunology
-
Lymphocyte Count -
-
Male -
-
Mice -
-
Mice, Inbred C57BL -
-
Middle Aged -
-
Mycosis Fungoides - pathology
-
RNA Interference -
-
RNA, Small Interfering - genetics
-
STAT3 Transcription Factor - genetics
-
STAT3 Transcription Factor - metabolism
-
STAT5 Transcription Factor - genetics
-
STAT5 Transcription Factor - metabolism
-
T-Lymphocytes, Regulatory - immunology
-
Tumor Suppressor Proteins - genetics
-
Tumor Suppressor Proteins - metabolism